News

Patients with sepsis and septic lung injury could have a better chance of survival and recover more quickly when treated with vitamin C infusions.

As a pathologist at the University of Kentucky, Dr. Charles Lutz helps patients behind the scenes, matching patients who need both solid organ and bone marrow transplants with appropriate donors. But when he was diagnosed with an aggressive prostate cancer in 2011, Lutz found himself on the other side of the table.

In its ongoing efforts to offer Kentuckians the latest, most innovative cancer treatments available, the UK Markey Cancer Center recently launched the Precision Medicine Clinic, a new space dedicated to providing patients with increased access to phase I and phase II clinical trials.

In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.

A faculty development opportunity on November 9th, 2017 will highlight CCTS resources, funding and expertise to move your research to the next level.

The Center for Clinical and Translational Science, in conjunction the Western States Consortium, is currently accepting applications for innovative, translational research projects that involve two or more institutions within the Consortium.

A newly proposed clinical trial could change how deadly triple-negative breast cancer is treated.

Doug Andres is exploring the link between RIT1 mutations and lung cancer.

The lab is assessing strength, endurance, gait, and balance to prevent and better rehab injuries.

UK and UAB will explore how Metformin may improve muscle growth response in older adults.